ClinicalTrials.Veeva

Menu

Text Messaging and Atopic Dermatitis

Northwestern University logo

Northwestern University

Status

Completed

Conditions

Atopic Dermatitis

Treatments

Procedure: Text message to cell phone

Study type

Interventional

Funder types

Other

Identifiers

NCT01216059
STU29486

Details and patient eligibility

About

Atopic dermatitis is a common problem faced by patients of all ages and backgrounds. Treatment regimens and specific therapies may be time consuming and multiple studies have documented a parallel decrease in compliance as time after an office visit increases. The adolescent population is an extremely challenging sub-group of patients in terms of complying with a treatment regimen. Not only are they striving for independence and thus lacking supervision of a regimen by a parent, but their complex thinking skills are immature, leading to forgetful behavior. By introducing a reminder system for these vulnerable patients that is easily incorporated into their daily lives, the investigators propose that patients will have better compliance at applying their medication and thus improving their atopic dermatitis. Text-messaging via cell phones has become very popular among teenagers and adults and provides a non-obtrusive method of sending a treatment reminder.

Full description

We propose to conduct a randomized, controlled 6-week trial to evaluate the impact of a text message-based reminder program on adherence to health maintenance behaviors among adolescents diagnosed with Atopic Dermatitis. After obtaining informed consent, subjects will be randomized into either an intervention or control group. Subjects in the intervention group will receive a daily text message with a tailored message regarding atopic dermatitis, while control group subjects will receive a weekly text message with information on local weather, sport or news without any reference to atopic dermatitis. Of note, the decision to send a weekly text message to the control group reflects the expectation that a message will be sent, although the frequency and content of the message will not be revealed.

Enrollment

26 patients

Sex

All

Ages

10 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 10-17 inclusive
  • Capable of giving informed consent/assent. Of note, all subjects will sign an assent form and parents will sign a parent consent form.
  • Diagnosed with Atopic Dermatitis by a physician (self report)
  • IGA score fo 2 or greater
  • Currently using at least one prescribed topical therapy for atopic dermatitis
  • Have a mobile phone capable of receiving text messages
  • Able to retrieve text messages from mobile phone
  • Able to adhere to study visit schedule and other protocol requirements.

Exclusion criteria

  • Younger than 10 years of age or 18 years and older at the time of enrollment
  • No diagnosis of atopic dermatitis by a physician
  • IGA score of 0 or 1
  • Currently on no prescribed topical treatment for atopic dermatitis
  • UV therapy or climatotherapy is a part of treatment for atopic dermatitis
  • Does not have a mobile phone capable of receiving text messages
  • Unable to retrieve text message
  • Non-English speaking individuals (text messages are in English)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

26 participants in 2 patient groups

Intervention group
Experimental group
Description:
Subjects will receive daily text message reminder about their treatment for atopic dermatitis during the 6 weeks of the study.
Treatment:
Procedure: Text message to cell phone
Control Group
No Intervention group
Description:
Subjects will receive a weekly text message reminder about pop-culture, sports or weather.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems